Mirion Technologies, Inc. (MIR) FY2026 Q2 P&L / Income Statement

Mirion Technologies, Inc. (MIR) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

266,800,000 US dollars

Total cost of revenues

133,700,000 US dollars

Gross profit

133,100,000 US dollars

Total operating expenses

115,200,000 US dollars

Income from operations

17,900,000 US dollars

Other income (expense), net (calculated)

negative 6,600,000 US dollars

Income before income taxes

11,300,000 US dollars

Income tax expense (benefit)

3,200,000 US dollars

Net income

8,100,000 US dollars

Medical - Cancer care

62,800,000 US dollars

Medical - Other

17,800,000 US dollars

Nuclear & Safety - Labs and research

29,100,000 US dollars

Nuclear & Safety - Nuclear

118,100,000 US dollars

Nuclear & Safety - Other

39,000,000 US dollars

Selling, general and administrative

105,100,000 US dollars

Research and development

10,100,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Mirion Technologies, Inc.: $7.70 M; to noncontrolling interests: $400.00 K.